OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...

Dr. Makary argues for more humility from the medical establishment and common sense when reviewing experimental drugs for ...

Drug firm Indoco Remedies Ltd on Monday (March 10) announced that its clinical research win AnaCipher, based in Hyderabad, ...

JB Chemicals & Pharmaceuticals said that the company's formulations manufacturing facility- T20, which is located at GIDC, Panoli (Gujarat), was inspected by the United States Food and Drug ...

Zydus Lifesciences Limited received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture ...

Joseph Shea, who sells athletic wear in Myrtle Beach, South Carolina, wonders and worries about the food he eats.

At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...

The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...

Sun Pharma will acquire Checkpoint Therapeutics for $355 million, expected to close by Q2 2025. The deal strengthens Sun ...

Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...

Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the ...